The New York Course 2021 Virtual

 

The New York Course 2021 Virtual
C

How is HBV Cure Defined? Is HBsAg Decline a Useful Intermediate Endpoint in Evaluating Treatments?

By The New York Course 2021 Virtual FEATURING Chloe Thio
By The New York Course 2021 Virtual FEATURING Chloe Thio
5 views
July 6, 2021
Comments 0
Login to view comments. Click here to Login
Videos
14:17

HIV Treatment Guidelines, Developments, and Studies: Can Neutralizin…

The New York Course 2021 Virtual

M. Cohen

73 views
09:40

Combination Prevention for COVID-19: What Lessons from the HIV Pande…

The New York Course 2021 Virtual

M. Cohen

7 views
16:08

COVID-19 Monoclonal Antibody Applications: How Have Variants Affecte…

The New York Course 2021 Virtual

M. Cohen

1.3K views
30:14

HIV Treatment Case Studies: Challenges, Causes, Implications, and Tr…

The New York Course 2021 Virtual

P. Sax

60 views
20:57

HIV-Associated Non-alcoholic Fatty Liver Disease: Diagnosis, Testing…

The New York Course 2021 Virtual

R. Chung

9 views
39:10

40 Years of HIV: Trials, Triumphs, and What's to Come

The New York Course 2021 Virtual

A. Levine

9 views
27:02

Diabetes Management: How to Manage Diabetes in Persons Living With H…

The New York Course 2021 Virtual

T. Brown

149 views
40:03

HIV Prevention and Combination Prevention for COVID-19

The New York Course 2021 Virtual

M. Cohen

6 views
32:06

Hepatitis C Elimination: What Are the Current Recommendations for Me…

The New York Course 2021 Virtual

O. Falade-Nwulia

33 views
19:56

HIV Prevention and Transmission: How Do Current Behavioral and Biome…

The New York Course 2021 Virtual

L. Mena

19:14

Quantification of Hepatic Fibrosis: How to Evaluate

The New York Course 2021 Virtual

J. Reinus

110 views
23:36

Do Broadly Neutralizing Antibodies Show Promise as Long Acting Agent…

The New York Course 2021 Virtual

D. Kuritzkes

9 views
06:11

Bamlanivimab for Prevention of COVID-19 and Emerging Resistance to V…

The New York Course 2021 Virtual

D. Kuritzkes

1.2K views
28:58

Is the COVID-19 Pandemic a Catalyst for Differentiated Care Models t…

The New York Course 2021 Virtual

W. Armstrong

12 views
34:21

Patients With Drug Resistant HIV: Unmet Needs for Prevention and Ben…

The New York Course 2021 Virtual

R. Bedimo

09:52

2021 Syphilis Treatment Guidelines: How Common Are Repeat Infections?

The New York Course 2021 Virtual

J. Marrazo

34 views
14:33

2021 Update to CDC’s Treatment Guidelines for Gonococcal Infection: …

The New York Course 2021 Virtual

J. Marrazo

84 views
06:12

2021 Update on STI-PEP and STI Immunizations

The New York Course 2021 Virtual

J. Marrazo

11 views
16:21

COVID-19 in Patients With HIV: Overview of Presenting Characteristic…

The New York Course 2021 Virtual

R. Gulick

7 views
12:43

COVID-19 and HIV: What Are the Recommendations for Triage, Managemen…

The New York Course 2021 Virtual

R. Gulick

545 views
17:56

How is HBV Cure Defined? Is HBsAg Decline a Useful Intermediate Endp…

The New York Course 2021 Virtual

C. Thio

10:56

Hepatitis B Infection: Is a Cure Achievable Based on Current Therapi…

The New York Course 2021 Virtual

C. Thio

9 views